Patricia Callahan

The congressional subcommittee launched its inquiry in response to a ProPublica investigation, finding several companies created tests that were “nearly impossible to fail.” Now it’s asking state and federal regulators to investigate too.

A CDC lab involved in making faulty coronavirus tests sent to state and local officials early in the pandemic was closed down hours after an October investigation by ProPublica exposed key mistakes the CDC made in manufacturing those tests.

A co-leader of a group of 18 attorneys general calls ProPublica’s story about the lack of side-impact tests for children’s booster seats “horrifying” and says it’s about time federal regulators stepped in to protect kids.

The Booster Seat Safety Act was prompted by a ProPublica investigation and a subsequent congressional probe that found manufacturers had misled parents about the safety of booster seats and endangered children’s lives.

The Booster Seat Safety Act was prompted by a ProPublica investigation and a subsequent congressional probe that found manufacturers had misled parents about the safety of booster seats and endangered children’s lives.

The inspection comes after a ProPublica investigation revealed that drugs made at the Glenmark Pharmaceuticals plant accounted for an outsized share of U.S. recalls for pills that didn’t dissolve properly and could harm people.

The move — along with the CDC’s explanation — is a sign that the nation’s top public health agency may be falling in line under HHS Secretary Robert F. Kennedy Jr., a longtime critic of vaccines.

FDA inspectors found serious problems at a Glenmark factory in India that manufactured the recalled drugs. Another medication made there has been tied to deaths of U.S. patients.

The Vaccine Injury Compensation Program stabilizes the nation’s childhood immunization system while paying those harmed by rare side effects. If the program topples, it could threaten access to vaccines.

In a warning letter, the Food and Drug Administration said Glenmark Pharmaceuticals failed to properly investigate flaws with a generic drug that ProPublica found was linked to U.S. deaths.